Sanofi
10% Owner
2 filings on record here, covering LTGO, ATTO. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-12
| Convert | LTGO | Latigo Biotherapeutics, Inc. | |
| Convert | LTGO | Latigo Biotherapeutics, Inc. | |
| Convert | LTGO | Latigo Biotherapeutics, Inc. | |
| Convert | LTGO | Latigo Biotherapeutics, Inc. | |
CORPORATEFiled 2026-08-07
| Convert | ATTO | Attovia Therapeutics, Inc. | |
| Buy | ATTO | Attovia Therapeutics, Inc. | $5,100,000 |
| Convert | ATTO | Attovia Therapeutics, Inc. | |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.